Academic Conference
Celebrating Wuhan Heer's Great Success at the 12th National Obstetrics and Gynecology Academic Conference of the Chinese Medical Association
From October 28 to 30, 2016, the 12th National Obstetrics and Gynecology Academic Conference of the Chinese Medical Association was held grandly at the Xiamen International Conference and Exhibition Center, with more than 5,000 obstetrics, gynecology, and pathology experts in attendance. Heer Medical participated actively with the SPICM-DNA Fully Automatic Cell Tumor Screening and Analysis System, receiving widespread recognition.
In order to strengthen academic exchange in obstetrics and gynecology, promote discipline development, and improve the clinical diagnosis, treatment, and research capabilities of obstetricians and gynecologists nationwide, the 12th National Obstetrics and Gynecology Academic Conference of the Chinese Medical Association was held grandly at the Xiamen International Conference and Exhibition Center from October 28 to 30. The conference aimed to "integrate resources, elevate concepts, standardize diagnosis and treatment, and promote development." During the event, the conference invited renowned domestic and international experts and scholars to deliver lectures on the latest advances in basic and clinical research across all areas of obstetrics and gynecology, and to engage in exchange and discussion on related academic issues. The conference attracted more than 5,000 obstetrics, gynecology, and pathology experts, directors, and technical specialists from across the country. Heer Medical Technology, as a high-tech enterprise producing early tumor screening equipment, actively participated in this grand event.
With the goals of broadening horizons, expanding thinking, and learning from best practices, Heer fully utilized the opportunity provided by this gynecology annual conference to engage in active and extensive exchange and communication with experts and technical specialists from across the country. The company's reputation and influence within the industry were further expanded. During the exhibition, Heer Medical demonstrated and operated the independently developed "SPICM-DNA Fully Automatic Cell Tumor Screening and Analysis System," attracting a large number of gynecology experts to stop and observe and seek consultation. Our company's technicians answered every attendee's questions in detail during the equipment demonstration, and engaged in in-depth discussions with on-site clinicians, technical specialists, and numerous distributors on the clinical application and market development prospects of DNA ploidy analysis technology.
